Monte Rosa Therapeutics, Inc. (GLUE)
NASDAQ: GLUE · Real-Time Price · USD
6.22
-0.41 (-6.18%)
At close: Feb 21, 2025, 4:00 PM
6.30
+0.08 (1.29%)
After-hours: Feb 21, 2025, 4:01 PM EST
Monte Rosa Therapeutics Market Cap
Monte Rosa Therapeutics has a market cap or net worth of $382.13 million as of February 21, 2025. Its market cap has increased by 50.56% in one year.
Market Cap
382.13M
Enterprise Value
183.64M
1-Year Change
50.56%
Ranking
Category
Stock Price
$6.22
Market Cap Chart
Since the IPO on June 24, 2021, Monte Rosa Therapeutics's market cap has decreased from $845.31M to $382.13M, a decrease of -54.79%. That is a compound annual growth rate of -19.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 382.13M | -10.37% |
| Dec 31, 2024 | 426.37M | 50.74% |
| Dec 29, 2023 | 282.85M | -23.21% |
| Dec 30, 2022 | 368.32M | -61.22% |
| Dec 31, 2021 | 949.65M | 12.34% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.71B |
| UnitedHealth Group | 429.24B |
| Novo Nordisk | 391.83B |
| Johnson & Johnson | 390.76B |
| AbbVie | 356.74B |
| Abbott Laboratories | 234.01B |
| AstraZeneca | 229.50B |
| Merck & Co. | 226.40B |